Spin-out Merge Labs aims to rival Elon Musk’s brain-chip company Neuralink. But researchers say the technology is still at an early stage.
Figure 1: The extension of modular proteins with the AFM. Figure 2: Identification of an unfolding intermediate in the extension of I27 and the prevention of this intermediate by a point mutation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results